Wang Lai's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Jun 18, 2026
- Accession no.
- 0001852291-26-000006
- Filed
- Jun 18, 2026
- Trade date
- Jun 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $310.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wang LaiCIK 0001852291 | Officer (President, Global Head of R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | American Depositary Shares | SSaleDisposed | −1,169 | $265.39 | −$310,240.91 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.